Takeda Pharmaceutical Co ADR’s filing revealed that its President, Plasma-Derived Ther Giles Richard Platford acquired Company’s shares for reported $0.28 million on Aug 23 ’24. In the deal valued at $14.94 per share,19,073 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares, generating $29,999,994 in total proceeds. Upon selling the shares at $8.10, the 10% Owner now owns 3,755,583 shares.
BofA Securities upgraded its Takeda Pharmaceutical Co ADR [TAK] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cowen’s analysts, who increased its forecast for the stock in mid July from “a Market perform” to “an Outperform”. Morgan Stanley also remained covering TAK and has decreased its forecast on October 07, 2021 with a “an Equal-weight” recommendation from previously “an Overweight” rating. JP Morgan revised its rating on April 19, 2021. It rated TAK as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TAK
On Tuesday, Takeda Pharmaceutical Co ADR [NYSE:TAK] saw its stock fall -0.21% to $14.30. Over the last five days, the stock has gained 0.14%. Takeda Pharmaceutical Co ADR shares have risen nearly 0.21% since the year began. Nevertheless, the stocks have fallen -5.67% over the past one year. While a 52-week high of $15.47 was reached on 08/23/24, a 52-week low of $12.57 was recorded on 06/20/24. SMA at 50 days reached $14.52, while 200 days put it at $14.00.
Levels Of Support And Resistance For TAK Stock
The 24-hour chart illustrates a support level at 14.25, which if violated will result in even more drops to 14.21. On the upside, there is a resistance level at 14.34. A further resistance level may holdings at 14.39. The Relative Strength Index (RSI) on the 14-day chart is 41.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.66%. Stochastics %K at 23.24% indicates the stock is a holding.
How much short interest is there in Takeda Pharmaceutical Co ADR?
A steep rise in short interest was recorded in Takeda Pharmaceutical Co ADR stocks on 2024-09-13, growing by 1.96 million shares to a total of 8.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 6.43 million shares. There was a rise of 23.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 01, 2019 when Cowen began covering the stock and recommended ‘”a Market perform”‘ rating along with a $19.50 price target.
